
Therapeutic Experience
Managed / Directed more than 350 clinical trials Phases I-IV
Project Manager Experience - 26 studies in patient populations
-
Immunology / Inflammation (6 Phase II/III studies)
-
Wound healing
-
Soft tissue inflammation
-
-
Endocrinology / Metabolism (4 Phase 1b/II studies)
-
Obesity
-
Growth hormone deficiency
-
Acromegaly
-
Pituitary/adrenal disorders
-
-
Dermatology (4 Phase II/III studies)
-
Atopic dermatitis
-
Burn itch
-
Acne vulgaris
-
-
Infectious Disease (2 Phase IIa studies)
-
Influenza vaccine
-
Oral warts
-
-
Oncology (7 Phase I-IV studies)
-
Breast
-
Lung
-
Prostate
-
Melanoma
-
Kidney
-
-
Pulmonary (2 Phase IIa studies)
-
Asthma (exercise and allergen induced)
-
-
Genitourinary (1 Phase 1 study)
-
Erectile dysfunction
-
Project / Program Oversight Experience - 79 studies in patient populations
-
Immunology / Inflammation (1 Phase 1b study)
-
Rheumatoid Arthritis
-
-
Endocrinology / Metabolism (7 Phase Ib/IIa studies)
-
Type II Diabetes
-
Obesity
-
-
Dermatology (3 Phase Ib/IIa studies)
-
Atopic dermatitis
-
Psoriasis
-
-
Cardiovascular (3 Phase Ib, IV studies)
-
Hypercholesterolemia
-
Hear failure
-
-
Neurology (13 Phase Ib/IIa studies)
-
Anesthetic
-
Pain (non-inflammatory)
-
Migraine
-
Alzheimer's Disease
-
Amyotrophic Lateral Sclerosis
-
Parkinson's Disease
-
-
Psychiatry (8 Phase Ib/II studies)
-
Schizophrenia
-
Major Depressive Disorder
-
Generalized Anxiety Disorder
-
-
Infectious Disease (1 Phase IIa study)
-
Hepatitis C
-
-
Oncology (16 Phase I-III studies)
-
Ovarian
-
Sarcomas
-
Gastric
-
Hepatic
-
Adenoid Cystic Carcinoma
-
Solid tumors (various)
-
Melanoma
-
Pancreatic
-
Colorectal
-
Breast
-
-
Gastroenterology / Hepatology (7 Phase Ib/IIa studies)
-
Gastroparesis
-
Inflammatory Bowel Disease
-
Irritable Bowel
-
NASH
-
-
Pulmonary (9 Phase IIa/II studies)
-
Tobacco - risk reduction
-
Idiopathic pulmonary fibrosis
-
-
Genitourinary (2 Phase IIa, IV)
-
Chronic Kidney Disease
-
Hyperphosphatemia
-
-
Rare Diseases (7 Phase IIa/III)
-
Mitochondrial Respiratory Chain Disease
-
Tumor-induced osteomalacia
-
Epidermal Nevus Syndrome
-
X-linked Hypophasphatemic Osteomalacia
-
Gaucher's Disease
-
-
Ophthalmology (2 Phase II/III studies)
-
Age-related macular degeneration
-
Clinical Pharmacology Project Management / Oversight - 245 studies in healthy subjects
-
Single Ascending Dose (SAD)
-
Multiple Ascending Dose (MAD)
-
Human Absorption / Metabolism / Excretion (hAME) - 14C radiolabeled
-
Drug-drug Interaction (DDI)
-
Cardiac safety (including thorough QTc [TQT])
-
Food Effect
-
Gastric pH
-
Renal Impairment
-
Hepatic Impairment
-
Bioequivalence (BE)
-
Bioavailability (BA)
-
Biocompatibility
-
Age and gender
-
Ethnic Bridging
-
PK / PD (clinical pharmacokinetics / pharmacodynamics)